The cohort included squamous cell carcinoma (n = 8), adenocarcinoma (n = 9), large cell neuroendocrine carcinoma (n = 3), and adenosquamous carcinoma (n = 1) by histology; 1 tumor harbored an EGFR activating mutation. The gene discussed is EGFR; the disease is squamous cell carcinoma.